(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2(Date:10/9/2008)... Clinical Results Expected in November 2008, BOTH... Pharma, Inc.,(Amex: DDD ) announced today the co...third of its three pivotal trials to evaluate the ...extended-release (ER) ibuprofen for,the over-the-c... top-line,results from this pivotal trial in Novem...
(Date:10/8/2008)...ce Will Reduce Animal Use in Cosmetics and Chemica...- MatTek Corp. today announced,that results of a r...,"catch-up" validation study on MatTek,s EpiDerm i...ults demonstrated the required sensitivity and,spe... alternative to animal,testing for determining hum...
(Date:10/8/2008)...l University Food Scientists Expand Testing Using ...y Assay, PORTLAND, Maine, Oct. 8 /- ... with the release of results from a new study,show...mmonly consumed,fruits like apples, bananas, red g...he Cellular Antioxidant Activity (CAA) assay. New ...
(Date:10/8/2008)...ratory study shows clinical improvement in patient... -- Current treatment options have limited bene...e and incurable blood vessel disease, -- Imatin... of certain cancers, known to inhibit protein...plore potential of imatinib mesylate in PAH in ...
Breaking Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12Genesis Pharmaceuticals Changes Auditors 14020 1Genesis Pharmaceuticals Changes Auditors 14020 2Alexion to Present at Investor Conferences 14016 1PAREXEL International to Present at Lehman Brothers 11th Annual Global Healthcare Conference 3866 1PAREXEL International to Present at Lehman Brothers 11th Annual Global Healthcare Conference 3866 2Pepperdine Business Plan Competition Awards 2426 000 to MBA Teams 14012 1Pepperdine Business Plan Competition Awards 2426 000 to MBA Teams 14012 2Pepperdine Business Plan Competition Awards 2426 000 to MBA Teams 14012 3...TOL, Tenn., May 09, 2007,/PRNewswire-FirstCall/ --...ls, Inc. today announced plans to present the resu... with erectile,dysfunction (ED). The presenters ar..., Department of Urology, NYU School of Medicine;,S...se Western,Reserve School of Medicine and Christop...
...Cervical Cancer and Other Human,Papillomavirus Rel...p in Large Phase III Clinical Studies Which Includ...f Medicine publishes the most comprehensive,and ro...ccine , LYON, France, 10th May2007 – New cli... efficacy of Gardasil® in the,prevention of ce...
Other Medicine Technology:Palatin Technologies and King Pharmaceuticals Announce Plan To,Present Results of Bremelanotide Phase 2b Studies in Men With,Erectile Dysfunction 2Palatin Technologies and King Pharmaceuticals Announce Plan To,Present Results of Bremelanotide Phase 2b Studies in Men With,Erectile Dysfunction 3Palatin Technologies and King Pharmaceuticals Announce Plan To,Present Results of Bremelanotide Phase 2b Studies in Men With,Erectile Dysfunction 4Gardasil Demonstrates Up to 100% Efficacy 2Gardasil Demonstrates Up to 100% Efficacy 3Gardasil Demonstrates Up to 100% Efficacy 4Gardasil Demonstrates Up to 100% Efficacy 5Gardasil Demonstrates Up to 100% Efficacy 6Gardasil Demonstrates Up to 100% Efficacy 7